Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
Titel:
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
Auteur:
Jabbour, Elias Kantarjian, Hagop Ravandi, Farhad Thomas, Deborah Huang, Xuelin Faderl, Stefan Pemmaraju, Naveen Daver, Naval Garcia-Manero, Guillermo Sasaki, Koji Cortes, Jorge Garris, Rebecca Yin, C Cameron Khoury, Joseph D Jorgensen, Jeffrey Estrov, Zeev Bohannan, Zachary Konopleva, Marina Kadia, Tapan Jain, Nitin DiNardo, Courtney Wierda, William Jeanis, Vicky O'Brien, Susan